Standardising outcome reporting for clinical trials of interventions for heavy menstrual bleeding: Development of a core outcome set.


Journal

BJOG : an international journal of obstetrics and gynaecology
ISSN: 1471-0528
Titre abrégé: BJOG
Pays: England
ID NLM: 100935741

Informations de publication

Date de publication:
10 2023
Historique:
revised: 20 02 2023
received: 16 09 2022
accepted: 22 02 2023
medline: 4 9 2023
pubmed: 14 4 2023
entrez: 13 4 2023
Statut: ppublish

Résumé

To develop a core outcome set for heavy menstrual bleeding (HMB). Core outcome set (COS) development methodology described by the COMET initiative. University hospital gynaecology department, online international survey and web-based international consensus meetings. An international collaboration of stakeholders (clinicians, patients, academics, guideline developers) from 20 countries and 6 continents. Phase 1: Systematic review of previously reported outcomes to identify potential core outcomes. Phase 2: Qualitative studies with patients to identify outcomes most important to them. Phase 3: Online two-round Delphi survey to achieve consensus about which outcomes are most important. Phase 4: A consensus meeting to finalise the COS. Outcome importance was assessed in the Delphi survey on a 9-point scale. From the 'long list' of 114, 10 outcomes were included in the final COS: subjective blood loss; flooding; menstrual cycle metrics; severity of dysmenorrhoea; number of days with dysmenorrhoea; quality of life; adverse events; patient satisfaction; number of patients going on to have further treatment for HMB and haemoglobin level. The final COS includes variables that are feasible for use in clinical trials in all resource settings and apply to all known underlying causes of the symptom of HMB. These outcomes should be reported in all future trials of interventions, their systematic reviews, and clinical guidelines to underpin policy.

Identifiants

pubmed: 37055716
doi: 10.1111/1471-0528.17473
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1337-1345

Subventions

Organisme : Academy of Medical Sciences
Pays : United Kingdom

Informations de copyright

© 2023 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd.

Références

National Institute for Health and Care Excellence. Heavy menstrual bleeding: assessment and management. 2018 [cited 2 September 2022]. Available from: https://www.nice.org.uk/guidance/cg44
National Institute for Health and Care Excellence. Heavy menstrual bleeding. London: RCOG Press; 2007.
Coulter A, Peto V, Jenkinson C. Quality of life and patient satisfaction following treatment for menorrhagia. Fam Pract. 1994;11(4):394-401.
Jones GL, Kennedy SH, Jenkinson C. Health-related quality of life measurement in women with common benign gynecologic conditions: a systematic review. Am J Obstet Gynecol. 2002;187(2):501-11.
Clark TJ, Khan KS, Foon R, Pattison H, Bryan S, Gupta JK. Quality of life instruments in studies of menorrhagia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2002;104(2):96-104.
Cote I, Jacobs P, Cumming DC. Use of health services associated with increased menstrual loss in the United States. Am J Obstet Gynecol. 2003;188(2):343-8.
Frick KD, Clark MA, Steinwachs DM, Langenberg P, Stovall D, Munro MG, et al. Financial and quality-of-life burden of dysfunctional uterine bleeding among women agreeing to obtain surgical treatment. Womens Health Issues. 2009;19(1):70-8.
Schoep ME, Adang EMM, Maas JWM, De Bie B, Aarts JWM, Nieboer TE. Productivity loss due to menstruation-related symptoms: a nationwide cross-sectional survey among 32 748 women. BMJ Open. 2019;9(6):e026186.
Munro MG, Critchley HOD, Fraser IS, FIGO Menstrual Disorders Committee. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynecol Obstet. 2018;143:393-408.
COMET Initiative. Core outcome measures in effectiveness trials. 2014 [cited 2 September 2022]. Available from: http://www.comet-initiative.org
Cooper NAM, Yorke S, Papadantonaki R, Khan KS. Variation of outcome reporting in studies of interventions for heavy menstrual bleeding: a systematic review. Facts Views Vis Obgyn. 2022;14(3):205-18. https://doi.org/10.52054/FVVO.14.3.030
Cooper NAM, Yorke S, Tan A, Khan KS, Rivas C. A qualitative study exploring the effect of heavy menstrual bleeding on women and their close associates: stakeholder involvement in development of a core outcome set. BMJ Open. 2023, in press.
Humphrey-Murto S, Wood TJ, Gonsalves C, Mascioli K, Varpio L. The Delphi method. Acad Med. 2020;95(1):168.
Jones J, Hunter D. Consensus methods for medical and health services research. BMJ. 1995;311(7001):376-80.
COMET initiative. DelphiManager [cited 2 September 2022]. Available from: http://www.comet-initiative.org/delphimanager/
Moss N, Daru J, Lanz D, Thangaratinam S, Khan KS. Involving pregnant women, mothers and members of the public to improve the quality of women's health research. BJOG. 2017;124(3):362-5.
Fitch K, Bernstein SJ, Aguilar MD, Burnand B, LaCalle JR, Lázaro P, et al. The RAND/UCLA appropriateness method user's manual. Santa Monica: RAND; 2001 [cited 12 January 2022]. Available from: https://www.rand.org/content/dam/rand/pubs/monograph_reports/2011/MR1269.pdf
Pratt JJ, Khan KS. Non-anaemic iron deficiency - a disease looking for recognition of diagnosis: a systematic review. Eur J Haematol. 2016;96(6):618-28.
Georgieff MK. Iron deficiency in pregnancy. Am J Obstet Gynecol. 2020;223(4):516-24.
Richards T, Musallam KM, Nassif J, Ghazeeri G, Seoud M, Gurusamy KS, et al. Impact of preoperative anaemia and blood transfusion on postoperative outcomes in gynaecological surgery. PLoS One. 2015;10(7):e0130861.
Peuranpää P, Heliövaara-Peippo S, Fraser I, Paavonen J, Hurskainen R. Effects of anemia and iron deficiency on quality of life in women with heavy menstrual bleeding. Acta Obstet Gynecol Scand. 2014;93(7):654-60.
Herman MC, Penninx JPM, Geomini PM, Mol BW, Bongers MY. Choice of primary outcomes evaluating treatment for heavy menstrual bleeding. BJOG. 2016;123:1593-98.
Rahn DD, Abed H, Sung VW, Matteson KA, Rogers RG, Morrill MY, et al. Systematic review highlights difficulty interpreting diverse clinical outcomes in abnormal uterine bleeding trials. J Clin Epidemiol. 2011;64(3):293-300.
COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) [cited 2 September 2022]. Available from: https://www.cosmin.nl/
Matteson KA, Scott DM, Raker CA, Clark MA. The menstrual bleeding questionnaire: development and validation of a comprehensive patient-reported outcome instrument for heavy menstrual bleeding. BJOG. 2015;122(5):681-9.
Matteson KA. Menstrual questionnaires for clinical and research use. Best Pract Res Clin Obstet Gynaecol. 2017;40:44-54.
ACOG reVITALize gynecology data definitions website [cited 2 September 2022]. Available from: https://www.acog.org/practice-management/health-it-and-clinical-informatics/revitalize-gynecology-data-definitions
Sharp HT, Johnson JV, Lemieux LA, Currigan C. Executive summary of the reVITALize initiative: standardizing gynecologic data definitions. Obstet Gynecol. 2017;129(4):603-7.

Auteurs

Natalie A M Cooper (NAM)

Women's Health Research Unit, Wolfson Institute of Population Health, Queen Mary University London, London, UK.

Carol Rivas (C)

Social Research Institute, UCL Institute of Education, London, UK.

Malcolm G Munro (MG)

Department of Obstetrics & Gynecology, David Geffen School of Medicine, University of California, Los Angeles, California, USA.

Hilary O D Critchley (HOD)

MRC Centre for Reproductive Health, University of Edinburgh, Edinburgh, UK.

T Justin Clark (TJ)

Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.

Kristen A Matteson (KA)

University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.

Rosa Papadantonaki (R)

Maxima Medisch Centrum, Veldhoven, The Netherlands.

Sarah Yorke (S)

Women's Health Research Unit, Wolfson Institute of Population Health, Queen Mary University London, London, UK.

Alex Tan (A)

Women's Health Research Unit, Wolfson Institute of Population Health, Queen Mary University London, London, UK.

Magdalena Bofill Rodriguez (M)

Department of Obstetrics and Gynaecology, University of Auckland, Auckland, New Zealand.

Marlies Bongers (M)

Department of Obstetrics and Gynaecology, Grow-School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.

Ayman Al-Hendy (A)

Department of Obstetrics and Gynecology, University of Chicago, Chicago, Illinois, USA.

Luis Bahamondes (L)

Department of Obstetrics and Gynaecology, School of Medical Sciences, Universidade Estadual de Campinas, Campinas, Brazil.

Anne Connolly (A)

Bevan Healthcare, Bradford, UK.

Cindy Farquhar (C)

Department of Obstetrics and Gynaecology, University of Auckland, Auckland, New Zealand.

Tanika Gray Valbrun (T)

The White Dress Project, Lithia Springs, Georgia, USA.

Martha Hickey (M)

Department of Obstetrics and Gynaecology, University of Melbourne and The Royal Women's Hospital, Melbourne, Victoria, Australia.

Hugh S Taylor (HS)

Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut, USA.

David Toub (D)

Medical Affairs, Gynesonics, Redwood City, California, USA.

Silvia Vannuccini (S)

Department of Obstetrics and Gynaecology, Careggi University Hospital, Florence, Italy.

Stamatina Iliodromiti (S)

Women's Health Research Unit, Wolfson Institute of Population Health, Queen Mary University London, London, UK.

Khalid Khan (K)

Department of Preventive Medicine and Public Health, University of Granada, Faculty of Medicine, Granada, Spain.
CIBER Epidemiology and Public Health, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH